Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer

被引:6
作者
Bucerius, J.
Ahmadzadehfar, H.
Hortling, N.
Joe, A. Y.
Palmedo, H.
Biersack, H-J
机构
[1] Univ Bonn, Dept Nucl Med, D-53105 Bonn, Germany
[2] Univ Bonn, Dept Radiol, D-5300 Bonn, Germany
[3] Gemeinschaftspraxis Radiol & Nukl Med, Siegburg, Germany
关键词
PSA; (18)FDG-PET/CT; prostate cancer;
D O I
10.1038/sj.pcan.4500959
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diagnosis of prostate cancer ( PC) still remains critical as non-invasive screening with prostate specific-antigen (PSA) lacks to indicate malignancy of the prostate in some cases. Recent research has shown that clinically meaningful PC can develop in patients with a PSA value < 4 ng/ml, frequently defined as upper limit of normal serum PSA levels. Furthermore, both morphological ( computed tomography (CT), magnetic resonance imaging, transrectal ultrasound) and functional imaging with 18 fluorodeoxyglucose positron emission tomography (FDG-PET) are associated with several limitations for primary diagnosis of PC. We report a case of an incidentally diagnosed PSA-negative PC by (18)FDG PET/CT in a patient with a previous diagnosis of a hypopharyngeal cancer.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 30 条
[1]   11C-acetate PET in the early evaluation of prostate cancer recurrence [J].
Albrecht, Susanne ;
Buchegger, Franz ;
Soloviev, Dmitri ;
Zaidi, Habib ;
Vees, Hansjoerg ;
Khan, Haleem G. ;
Keller, Alain ;
Delaloye, Angelika Bischof ;
Ratib, Osman ;
Miralbell, Raymond .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (02) :185-196
[2]  
Barbieri A, 1997, Acta Biomed Ateneo Parmense, V68, P23
[3]   [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse:: experience in 100 consecutive patients [J].
Cimitan, Marino ;
Bortolus, Roberto ;
Morassut, Sandro ;
Canzonieri, Vincenzo ;
Garbeglio, Antonio ;
Baresic, Tanja ;
Borsatti, Eugenio ;
Drigo, Annalisa ;
Trovo, Mauro G. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (12) :1387-1398
[4]  
de Jong IJ, 2003, J NUCL MED, V44, P331
[5]  
Dennis LK, 2000, PROSTATE, V42, P247
[6]   Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients [J].
Fricke, E ;
Machtens, S ;
Hofmann, M ;
van den Hoff, J ;
Bergh, S ;
Brunkhorst, T ;
Meyer, GJ ;
Karstens, JH ;
Knapp, WH ;
Boerner, AR .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (04) :607-611
[7]  
Gambhir SS, 2001, J NUCL MED, V42, p1S
[8]   Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen [J].
Gao, HW ;
Li, YL ;
Wu, S ;
Wang, YS ;
Zhang, HF ;
Pan, YZ ;
Zhang, L ;
Tateno, H ;
Sato, I ;
Kuwahara, M ;
Zhao, XJ .
ASIAN JOURNAL OF ANDROLOGY, 2005, 7 (02) :159-163
[9]   Prostate cancer: Emerging concepts .1. [J].
Garnick, MB ;
Fair, WR .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (02) :118-125
[10]   Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy [J].
Hofer, C ;
Laubenbacher, C ;
Block, T ;
Breul, J ;
Hartung, R ;
Schwaiger, M .
EUROPEAN UROLOGY, 1999, 36 (01) :31-35